Raltegravir - Merck & Co
At a glance
- Drug Originator Merck & Co
- Drug Licenced by Cipla; Medicines Patent Pool; Merck Canada
- Drug Class Antiretrovirals; Naphthyridines; Organic chemicals; Small molecules
- Mechanism of Action HIV integrase inhibitors
- USA Patent Applicants MSD SUB MERCK
- USA Patents 9
- NDAs 3
- International Patents 109
- Patent Applications 5,672
Disclaimer